EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+13.49%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.37B
AUM Growth
+$167M
(+14%)
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
120
Reduced
185
Closed
27
Top Buys
| 1 |
Microsoft
MSFT
|
$22.3M |
| 2 |
Pinduoduo
PDD
|
$13.5M |
| 3 |
NIO
NIO
|
$13.1M |
| 4 |
Marvell Technology
MRVL
|
$11.4M |
| 5 |
TSMC
TSM
|
$10.4M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$24.2M |
| 2 |
Legend Biotech
LEGN
|
$19.1M |
| 3 |
Trip.com Group
TCOM
|
$15.6M |
| 4 |
Zai Lab
ZLAB
|
$7.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$3.55M |
Sector Composition
| 1 | Consumer Discretionary | 36.1% |
| 2 | Technology | 29.22% |
| 3 | Communication Services | 14% |
| 4 | Healthcare | 8.72% |
| 5 | Real Estate | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
BioCryst Pharmaceuticals
BCRX
$1.74B
| $389K | 0.03% |
46,585
+6,330
| +16% | +$52.9K |
|
177
Madrigal Pharmaceuticals
MDGL
$9.65B
| $387K | 0.03% |
1,599
-3,933
| -71% | -$952K |
|
178
Walmart
WMT
$801B
| $385K | 0.03% |
7,839
-384
| -5% | -$18.9K |
|
179
Vaxcyte
PCVX
$4.29B
| $383K | 0.03% |
10,212
+279
| +3% | +$10.5K |
|
|
HZNP
180
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $383K | 0.03% |
3,510
-836
| -19% | -$91.2K |
|
181
Cytokinetics
CYTK
$6.34B
| $382K | 0.03% |
10,848
-958
| -8% | -$33.7K |
|
182
McDonald's
MCD
$224B
| $382K | 0.03% |
1,365
-50
| -4% | -$14K |
|
183
Iovance Biotherapeutics
IOVA
$901M
| $380K | 0.03% |
62,188
+1,236
| +2% | +$7.55K |
|
184
Copart
CPRT
$47B
| $379K | 0.03% |
10,088
-658
| -6% | -$24.7K |
|
185
United Therapeutics
UTHR
$18.1B
| $378K | 0.03% |
1,689
+181
| +12% | +$40.5K |
|
186
Align Technology
ALGN
$10.1B
| $377K | 0.03% |
1,128
-325
| -22% | -$109K |
|
187
Bristol-Myers Squibb
BMY
$96B
| $376K | 0.03% |
5,424
-41
| -0.8% | -$2.84K |
|
188
Workday
WDAY
$61.7B
| $375K | 0.03% |
1,817
-102
| -5% | -$21.1K |
|
189
Amicus Therapeutics
FOLD
$2.46B
| $374K | 0.03% |
33,758
-2,403
| -7% | -$26.6K |
|
190
Arrowhead Research
ARWR
$4.02B
| $373K | 0.03% |
14,679
+701
| +5% | +$17.8K |
|
191
AstraZeneca
AZN
$253B
| $373K | 0.03% |
5,370
-434
| -7% | -$30.1K |
|
192
Bank of America
BAC
$369B
| $372K | 0.03% |
13,001
-512
| -4% | -$14.7K |
|
193
Ironwood Pharmaceuticals
IRWD
$188M
| $372K | 0.03% |
35,319
-366
| -1% | -$3.86K |
|
194
Sarepta Therapeutics
SRPT
$1.96B
| $370K | 0.03% |
2,684
-889
| -25% | -$123K |
|
195
Twist Bioscience
TWST
$1.55B
| $369K | 0.03% |
24,474
+7,243
| +42% | +$109K |
|
196
Beam Therapeutics
BEAM
$2.11B
| $368K | 0.03% |
12,016
+1,981
| +20% | +$60.7K |
|
197
Veracyte
VCYT
$2.55B
| $368K | 0.03% |
16,507
+1,740
| +12% | +$38.8K |
|
198
Insmed
INSM
$30.7B
| $366K | 0.03% |
21,479
-1,418
| -6% | -$24.2K |
|
|
MRTX
199
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $366K | 0.03% |
9,847
-208
| -2% | -$7.73K |
|
|
RXDX
200
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $362K | 0.03% |
3,377
-459
| -12% | -$49.2K |
|